These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7962541)

  • 41. Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection.
    Rutigliano JA; Johnson TR; Hollinger TN; Fischer JE; Aung S; Graham BS
    J Virol; 2004 Mar; 78(6):3014-23. PubMed ID: 14990720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.
    Iqbal M; Lin W; Jabbal-Gill I; Davis SS; Steward MW; Illum L
    Vaccine; 2003 Mar; 21(13-14):1478-85. PubMed ID: 12615444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus.
    Tang YW; Neuzil KM; Fischer JE; Robinson FW; Parker RA; Graham BS
    Vaccine; 1997; 15(6-7):597-602. PubMed ID: 9178456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells.
    Anderson LJ; Tsou C; Potter C; Keyserling HL; Smith TF; Ananaba G; Bangham CR
    J Infect Dis; 1994 Nov; 170(5):1201-8. PubMed ID: 7963714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses.
    Melendi GA; Bridget D; Monsalvo AC; Laham FF; Acosta P; Delgado MF; Polack FP; Irusta PM
    Virus Genes; 2011 Feb; 42(1):46-54. PubMed ID: 21053062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the T helper cell response induced by respiratory syncytial virus and its fusion protein in BALB/c mice.
    Bright H; Turnbull T; Toms GL; Scott R
    Vaccine; 1995 Jul; 13(10):915-22. PubMed ID: 7483764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.
    Cannon MJ; Openshaw PJ; Askonas BA
    J Exp Med; 1988 Sep; 168(3):1163-8. PubMed ID: 3262705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?
    Siegrist CA; Saddallah F; Tougne C; Martinez X; Kovarik J; Lambert PH
    Vaccine; 1998; 16(14-15):1473-8. PubMed ID: 9711791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine.
    Trudel M; Nadon F; Séguin C; Brault S; Lusignan Y; Lemieux S
    Vaccine; 1992; 10(2):107-12. PubMed ID: 1539463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-4 Predicts the Efficacy of a Candidate Antioxycodone Vaccine and Alters Vaccine-Specific Antibody-Secreting Cell Proliferation in Mice.
    Crouse B; Baehr C; Hicks D; Pravetoni M
    J Immunol; 2023 May; 210(9):1272-1280. PubMed ID: 36939374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient.
    Mountz JD; Gao M; Ponder DM; Liu S; Sun CW; Alduraibi F; Sullivan K; Pat B; Dell'Italia LJ; Hsu HC
    Clin Immunol; 2022 Nov; 244():109130. PubMed ID: 36189576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses.
    Gartlan C; Tipton T; Salguero FJ; Sattentau Q; Gorringe A; Carroll MW
    Front Immunol; 2022; 13():882972. PubMed ID: 35444667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Using Murine Models to Understand Human Pathology.
    Shilovskiy IP; Yumashev KV; Nikolsky AA; Vishnyakova LI; Khaitov MR
    Biochemistry (Mosc); 2021 Mar; 86(3):290-306. PubMed ID: 33838630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effect of Unconventional Cytokine Combinations on NK-Cell Responses to Viral Infection.
    Ochayon DE; Waggoner SN
    Front Immunol; 2021; 12():645850. PubMed ID: 33815404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strategies for active and passive pediatric RSV immunization.
    Eichinger KM; Kosanovich JL; Lipp M; Empey KM; Petrovsky N
    Ther Adv Vaccines Immunother; 2021; 9():2515135520981516. PubMed ID: 33623860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders.
    Crouse B; Robinson C; Huseby Kelcher A; Laudenbach M; Abrahante JE; Pravetoni M
    NPJ Vaccines; 2020; 5():99. PubMed ID: 33101712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Function and Modulation of Type I Interferons during Respiratory Syncytial Virus Infection.
    Stephens LM; Varga SM
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32290326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.
    Wójtowicz A; Bibert S; Taffé P; Bernasconi E; Furrer H; Günthard HF; Hoffmann M; Osthoff M; Cavassini M; Bochud PY;
    AIDS; 2019 Sep; 33(11):1719-1727. PubMed ID: 31225812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytokines and CD8 T cell immunity during respiratory syncytial virus infection.
    Schmidt ME; Varga SM
    Cytokine; 2020 Sep; 133():154481. PubMed ID: 30031680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus.
    Agrawal AS; Tao X; Algaissi A; Garron T; Narayanan K; Peng BH; Couch RB; Tseng CT
    Hum Vaccin Immunother; 2016 Sep; 12(9):2351-6. PubMed ID: 27269431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.